Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records-Reference-Cited by-同舟云学术

Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records

Published:2018-05-23 Issue:11 Volume:2 Page:1172-1179
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Singh Ashima¹,Mora Javier¹,Panepinto Julie A.¹

Affiliation:

1. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

Abstract

Key Points The algorithms have high sensitivity and specificity to identify patients with hemoglobin SS/Sβ0 thalassemia and acute care pain encounters. Codes conforming to common data model are provided to facilitate adoption of algorithms and standardize definitions for EHR-based research.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/2/11/1172/882022/advances017541.pdf

Reference25 articles.

1. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members;Yawn;JAMA,2014

2. Identification and validation of a sickle cell disease cohort within electronic health records;Michalik;Acad Pediatr,2017

3. PCORnet. Common Data Model 3.1. Available at: http://www.pcornet.org/wp-content/uploads/2017/05/2017-05-01_Integrated-CDM-Specification-Implemeantion-Guidance-CDM-v....pdf. Accessed 31 January 2018.

4. Acute care utilization and rehospitalizations for sickle cell disease;Brousseau;JAMA,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease;Blood Advances;2023-12-29

2. The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease;Blood Advances;2023-06-30

3. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program’s Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study;JMIR Public Health and Surveillance;2023-06-28

4. Increasing Visibility of Sickle Cell Disease in Indiana: Establishing Baseline Prevalence Using Integrated Data From Multiple Sources;Public Health Reports;2023-05-26

5. Real-World Evidence on Disease Burden and Economic Impact of Sickle Cell Disease in Italy;Journal of Clinical Medicine;2022-12-23